PATENT CLAIM ANALYSIS

Application Number: 15918852
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "250000"]

Abstract:
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Claim (Index 1):
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of the compound of the structure: wherein the pharmaceutical composition is in the form of a liquid dosage form.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14452296', '15918834', '15918877', '14162637', '14712630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7246843269922623
- 35 USC 102 Novelty (BERT): 0.4773725981124913
- Combined Prediction Score: 0.6999531541042852
- Mean Citation Score: 197.08822
- Max Citation Score: 197.10783
- Similarity Product: 155.4515878883672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test